Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-25-002393
Filing Date
2025-08-26
Accepted
2025-08-26 16:18:44
Documents
1
Period of Report
2025-08-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312227001_08262025.html 3  
1 OWNERSHIP DOCUMENT form312227001_08262025.xml 3 5066
  Complete submission text file 0000921895-25-002393.txt   6544
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44, TOWER 100, THE TOWERS WINSTON CHURCHILL, PAITILLA PANAMA CITY R1 07196
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33678 | Film No.: 251257854